- G D Smith,
- M Egger
- Department of Public Health, University of Glasgow, Glasgow G12 8RZ
- Department of Social and Preventive Medicine, University of Berne, CH- 3012 Berne, Switzerland
- Correspondence to: Dr Davey Smith.
Recently, some authorities have called for a change in direction in health policy on blood cholesterol concentrations,1 while another group considers that current efforts are correct.2 The overviews by Law and colleagues can help us make up our minds regarding which, if either, opinion is correct.*RF 3-5*
Underestimation of risk of ischaemic heart disease
Following an old but increasingly popular tradition,6 Law and colleagues corrected the association between cholesterol concentration and risk of ischaemic heart disease for the attenuation (or regression dilution) due to measurement imprecision. Since cholesterol concentrations vary over time, prospective studies relating future risk of ischaemic heart disease to a single measurement will underestimate the true strength of the association. The adjustment is used because few epidemiological studies have obtained repeat measurements. As Spearman noted in 1904,6 however, such adjustments should be used carefully because they are not free of assumptions. They could be misleading if recent levels of a risk factor are more important determinants of disease than earlier levels; if peaks in the level of the risk factor, rather than the usual value, are the important aetiological factor; or if changes in risk factor levels are important.7 Some studies have been able to examine the association of average cholesterol concentration with risk of ischaemic heart disease directly.8,9 These have indicated that although the correction factors may overestimate the strength of the association between usual cholesterol concentration and risk of ischaemic heart disease, repeated cholesterol measurements identify people at increased risk of disease better than a single measurement.
Law et al have introduced an extension of the correction for attenuation, which they called correction for surrogate measurement bias. Since it is the low density lipoprotein component of total cholesterol which is considered to increase the risk of ischaemic heart disease they argue that the association of total …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012